Source: ALL

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Biomarker RGD [Effect of Bushen Huoxue Decoction on dopamine D2 receptor in the brain of rats with Parkinson's disease]. 22126770

2011
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Biomarker CTD_human Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade. 15469457

2004
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Therapeutic CTD_human Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade. 15469457

2004
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Therapeutic CTD_human Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. 12476322

2002
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Biomarker CTD_human Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. 12476322

2002
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Therapeutic CTD_human Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo. 9171869

1997
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
CUI: C0242422
Disease: Parkinsonian Disorders
Parkinsonian Disorders 		0.500 Biomarker CTD_human Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo. 9171869

1997